Award

Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems

NHS BLOOD & TRANSPLANT

This public procurement record has 1 release in its history.

Award

04 Mar 2021 at 15:03

Award Notice
Summary of the contracting process

The procurement process is led by NHS Blood & Transplant (NHSBT), which is seeking suppliers for Human Leucocyte Antigen (HLA) specific antibody detection and definition systems. This initiative falls under the medical equipment industry and takes place in various locations across the United Kingdom, including six laboratories. The open tender has been awarded with a total contract value of £7,143,000, and the contract period spans from 22nd February 2021 to 21st February 2025.

This contract represents a significant opportunity for businesses specialising in medical equipment, particularly those focused on diagnostic kits and maintenance services for medical technologies. Companies, especially small to medium enterprises (SMEs), that offer innovative solutions in antibody detection and definition systems, or maintenance of existing medical equipment, will find suitable avenues to engage in this market, supporting NHSBT in enhancing patient care through effective transplantation and transfusion practices.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems

Notice Description

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-a71e0ec5-9143-42dd-9ae5-623f6518a09a
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/f5f3ffa3-24e5-45ae-9180-f9e90a524fb4
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

38 - Laboratory, optical and precision equipments (excl. glasses)

50 - Repair and maintenance services

CPV Codes

33100000 - Medical equipments

33140000 - Medical consumables

33141625 - Diagnostic kits

38434540 - Biomedical equipment

50421000 - Repair and maintenance services of medical equipment

Notice Value(s)

Tender Value
£7,143,000 £1M-£10M
Lots Value
Not specified
Awards Value
£7,143,000 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
4 Mar 20214 years ago
Submission Deadline
14 Jan 2020Expired
Future Notice Date
Not specified
Award Date
11 Feb 20215 years ago
Contract Period
22 Feb 2021 - 21 Feb 2025 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD & TRANSPLANT
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS43 7QH
Post Town
Not specified
Country
Not specified
Major Region (ITL 1)
Not specified
Basic Region (ITL 2)
Not specified
Small Region (ITL 3)
Not specified
Delivery Location
Not specified
Local Authority
Not specified
Electoral Ward
Not specified
Westminster Constituency
Not specified

Supplier Information

Number of Suppliers
2
Supplier Names

IMMUCOR

VH BIO

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-a71e0ec5-9143-42dd-9ae5-623f6518a09a-2021-03-04T15:03:01Z",
    "date": "2021-03-04T15:03:01Z",
    "ocid": "ocds-b5fd17-a71e0ec5-9143-42dd-9ae5-623f6518a09a",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "tender_198620/930917",
        "title": "Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems",
        "description": "Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33100000",
            "description": "Medical equipments"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "33140000",
                "description": "Medical consumables"
            },
            {
                "scheme": "CPV",
                "id": "33141625",
                "description": "Diagnostic kits"
            },
            {
                "scheme": "CPV",
                "id": "38434540",
                "description": "Biomedical equipment"
            },
            {
                "scheme": "CPV",
                "id": "50421000",
                "description": "Repair and maintenance services of medical equipment"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 7143000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure (above threshold)",
        "tenderPeriod": {
            "endDate": "2020-01-14T12:00:00Z"
        },
        "contractPeriod": {
            "startDate": "2021-02-22T00:00:00Z",
            "endDate": "2025-02-21T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-160911",
            "name": "NHS Blood & Transplant",
            "identifier": {
                "legalName": "NHS Blood & Transplant"
            },
            "address": {
                "streetAddress": "500 North Bristol Park",
                "locality": "Bristol",
                "postalCode": "BS43 7QH",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "marta.drozdzowska@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-164273",
            "name": "VH Bio Ltd",
            "identifier": {
                "legalName": "VH Bio Ltd"
            },
            "address": {
                "streetAddress": "Unit 11b Station Approach, Team Valley Trading Estate, Gateshead, NE11 0ZF"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        },
        {
            "id": "GB-CFS-164299",
            "name": "Immucor",
            "identifier": {
                "legalName": "Immucor"
            },
            "address": {
                "streetAddress": "2 Cranbrook Way, Solihull Business Park, Solihull, West Midlands B90 4GT"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-160911",
        "name": "NHS Blood & Transplant"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-a71e0ec5-9143-42dd-9ae5-623f6518a09a-1",
            "status": "active",
            "date": "2021-02-11T00:00:00Z",
            "datePublished": "2021-03-04T15:03:01Z",
            "value": {
                "amount": 7143000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-164273",
                    "name": "VH Bio Ltd"
                },
                {
                    "id": "GB-CFS-164299",
                    "name": "Immucor"
                }
            ],
            "contractPeriod": {
                "startDate": "2021-02-22T00:00:00Z",
                "endDate": "2025-02-21T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/f5f3ffa3-24e5-45ae-9180-f9e90a524fb4",
                    "datePublished": "2021-03-04T15:03:01Z",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}